From Hit to Lead: Discovery of Novel Selective RIPK1 Inhibitor with Pyridoimidazole Scaffold for the Treatment of Autoimmune Diseases through Phenotypic Screening and Structural Optimization
1. 系统已在2026-02-11 11:15:52对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.5c03145
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c03145
其他信息:
出版社: American Chemical Society (ACS)
作者: Jihong Wan; Xiao-Yu Xiong; Zixiang Geng; Benjun Yuan; Youzhen Ma; Yan Zhao; Zhi Ying Dorothy Wong; Xinyi Kang; Rui Fan; Delin Min; Huanren Yan; Yibo Chen; Dong-Yi He; Jian-Ping Zuo; Han-Chen Xu; Yang Ding; Zhiyi Liu; Zixin Hu; Fuzhuo Li; Nannan Sun; Yongfang Zhao; Ze-Min Lin; Mei-Lin Tang
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c03145
